Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $30,627.00 |
|---|---|
| Enterprise Value | $-1,972,483.00 |
| Earnings per Share | $-0.36 |
| Beta | 3.29 |
| Outstanding Shares | 96,319,203 |
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | -24.08 |
| Enterprise Value to EBIT | 0.12 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.1 |
| Debt to Equity | 0.04 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
LifePoint, Inc. focuses on the development, production, and sale of the IMPACT Test System, a specialized device for diagnostic testing and screening. This product serves a wide array of markets, including businesses, emergency medical s...